SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ishita Drugs & Industries informs about Financial Results

30 May 2013 Evaluate

Ishita Drugs & Industries has informed about the Financial Results for the period ended March 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Ishita Drugs & Inds. Share Price

78.75 -0.75 (-0.94%)
11-Jun-2026 10:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.00
Dr. Reddys Lab 1273.80
Cipla 1382.85
Zydus Lifesciences 1101.30
Lupin 2257.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×